face 2005 template
TRANSCRIPT
DERMAL FILLERS
OUTLINE - ABSORBABLE POLYACRYLAMIDE
MEDICAL DISCLOSURE:
• Dr. Patrick J. Treacy is a Cosmetic Doctor registered in UK and Ireland
• I have previously been registered in United States, Australia, New Zealand and South Africa.
• I have no financial interest or stock in Syneron
• I receive no additional remuneration for product bought by you after attendance at this lecture.
REPLACE LOST TISSUE REPLACE LOST TISSUE VOLUMEVOLUME
• NOSE TO MOUTH LINES
• LIP AUGMENTATION
• LIPSTICK LINES
• MARIONETTE LINES
• CHEEK VOLUME
• FOREHEAD LINES, FROWN LINE
• CROWS FEET
COLLAGENCOLLAGEN
• CREATED THE MARKET • COSMETIC TREATMENTS NO LONGER THE
DOMAIN OF THE RICH AND FAMOUS• SAFE, AFFORDABLE, AVAILABLE• ALLERGY TO COLLAGEN• COLLAGENASES INDUCED – DURATION OF
ACTION SHORTER AND SHORTER• PATIENTS DEMORALISED – STOP
TREATMENT
HISTORY OF DERMAL FILLERS
• REPLACE LIKE WITH LIKE – COLLAGEN
• REPLACE LIKE WITH SIMILAR – HYALURONIC ACID
• REPLACE LIKE WITH ARTIFICIAL – NEWFILL
• SOPHISTICATION OF ARTIFICIAL FILLERS – ABSORBABLE POLYACRYLAMIDES
POLYACRYLAMIDE
• OCULAR IMPLANTS
• CONTACT LENSES
• ARTIFICIAL TEARS
• SUTURE MATERIAL – CARDIAC MICROSURGERY
• WATER FILTRATION
• WINE FILTRATION
OUTLINE = ABSORBABLE OUTLINE = ABSORBABLE POLYACRYLAMIDEPOLYACRYLAMIDE
• WEAK ESTER BONDS INSERTED INTO POLYACRYLAMIDE (PATENTED)
• METABOLISED BY TISSUE ESTERASES• SMALLER FRAGMENTS OF POLYACRYLAMIDE
ELIMINATED VIA BILE• PREDICTABLE BREAKDOWN; NON-TOXIC
METABILITES• CAN DEFINE LONGEVITY OF PRODUCT• CAN INJECT AT ALL TISSUE LEVELS
INSERTION OF WEAK ESTER INSERTION OF WEAK ESTER
BONDS: DEFINING LENGTHBONDS: DEFINING LENGTH
METABOLISM OF WEAK ESTER METABOLISM OF WEAK ESTER BONDS BY ESTERASESBONDS BY ESTERASES
THE OUTLINE FAMILYTHE OUTLINE FAMILY
• OUTLINE ORIGINAL
• OUTLINE ULTRA
• 150,000 SYRINGES IN 5 YEARS
OUTLINE ORIGINALOUTLINE ORIGINAL
• HALF LIFE 2 YEARS
• CLINICAL RESULTS 1 YEAR
• NOSE TO MOUTH LINES
• LIPS, LIPSTICK LINES
• MARIONETTE LINES
• CHEEK AUGMENTATION
• (FOREHEAD LINES, FROWN LINE)
• MID DERMIS; 30g NEEDLE
OUTLINE ORIGINAL 0, 4 WEEKS, 6 MONTHS0, 4 WEEKS, 6 MONTHS
FROWN LINE; 0 AND 1 YEARFROWN LINE; 0 AND 1 YEAR
OUTLINE ULTRA
• T ½ 5 YEARS
• CLINICAL RESULTS 2-3 YEARS
• DEEP LINES AND FOLDS
• NOSE TO MOUTH LINES
• POOR QUALITY LIPS
• SUBDERMAL INJECTION 27G
• BASE FOR ORIGINAL
INJECTION TECHNIQUESINJECTION TECHNIQUES
• ALWAYS RETROGRADE TUNNELLING
• MINIMISE PUNCTURE HOLES
• DO NOT OVER FILL
• FLATTEN GENTLY; DO NOT MASSAGE
• AVOID UV AND ALCOHOL 24 HOURS
• REPEAT 4 WEEKS + IF NECESSARY
CONTRAINDICATIONSCONTRAINDICATIONS
• AS FOR ALL INJECTABLE FILLERS:– ALLERGY (SKIN TEST AVAILABLE)– IMMUNOSUPRESSION– ACTIVE INFECTION– PREGNANCY, LACTATION– AUTOIMMUNITY – HERPES SIMPLEX VIRUS – ORAL ANTIVIRAL ESSENTIAL
FOR LIPS – CAUTION
• LET OTHER FILLERS GROW OUT• AVOID ARTECOLL SITES • SEVERELY ALLERGIC PEOPLE• SEVERELY ILL PEOPLE• WARFARIN OR OTHER ANTICOAGULANT TREATMENT• ASPIRIN, NSAIDS
OUTLINEOUTLINE
• VERSATILE RANGE OF FILLERS
• LONG LASTING
• NON-PARTICULATE, PREFILLED SYRINGE, CONSTANT VISCOSITY
• INJECT AT ALL LEVELS
• 30G NEEDLE
• ROOM TEMPERATURE
• SWELLS 3 HOURS ONLY
OUTLINE
• GOOD COST:BENEFIT RATIO
• GOOD SAFETY PROFILE
• EASY TO STORE AND TO USE
• 1ML AND 0,5ML SYRINGES
• PATIENT HAPPY
• DOCTOR HAPPY